Histopathological Features of Peripheral Nerve and Muscle in Mitochondrial Disease

ABSTRACT

Despite enormous strides in the molecular diagnosis of mitochondrial disease, this approach is currently applicable to only a minority of patients who are affected with these disorders. The phenotypic spectrum in this category of disease is large and, in the absence of genotypic confirmation, a pattern recognition paradigm is probably the most sensitive means to reinforce the suspicion of mitochondrial disease. Along with clinical, biochemical, radiographic, and electrophysiological markers, histopathological features from nerve and muscle biopsy are useful indices to factor into a complex equation permitting a presumptive diagnosis or to justify more elaborate diagnostic undertakings. The combination of electrophysiological evidence of demyelinating neuropathy on nerve conduction studies and mild myopathic features on electromyography is one such constellation that should instigate a high index of suspicion for mitochondrial disease. The histopathological hallmarks of mitochondrial cytopathies on muscle biopsy are the ``ragged-red fiber'' on light level evaluation and paracrystalline inclusions at the electron microscopic level. Neither of these is exclusive to mitochondrial disease and both may be identified among other nonspecific changes seen in biopsy specimens. Histopathological evaluation of muscle and nerve can provide information to reinforce the likelihood of mitochondrial disease or to indicate an alternative diagnosis as the more probable cause of a patient's symptoms.

KEYWORD

itochondria - muscle biopsy - nerve biopsy - histopathology - electrodiagnostic testing - ragged-red fiber - cytochrome oxidase - succinate dehydrogenase - paracrystalline inclusions - demyelinating neuropathy - node of Ranvier

REFERENCES

• 1 Leonard J V, Schapira A H. Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects.  Lancet . 2000;  355 389-394
• 2 Maertens P. Mitochondrial encephalopathies.  Semin Pediatr Neurol . 1996;  3 279-297
• 3 Sherratt E J, Thomas A W, Alcolado J C. Mitochondrial DNA defects: a widening clinical spectrum of disorders [editorial].  Clin Sci (Colch) . 1997;  92 225-235
• 4 Shoubridge E A. Mitochondrial encephalomyopathies.  Curr Opin Neurol . 1998;  11 491-496
• 5 Zeviani M, Amati P, Savoia A. Mitochondrial myopathies.  Curr Opin Rheumatol . 1994;  6 559-567
• 6 Zeviani M, Fernandez-Silva P, Tiranti V. Disorders of mitochondria and related metabolism.  Curr Opin Neurol . 1997;  10 160-167
• 7 Zeviani M, Corona P, Nijtmans L, Tiranti V. Nuclear gene defects in mitochondrial disorders.  Ital J Neurol Sci . 1999;  20 401-408
• 8 Brown M D, Wallace D C. Molecular basis of mitochondrial DNA disease.  J Bioenerg Biomembr . 1994;  26 273-289
• 9 Fadic R, Johns D R. Clinical spectrum of mitochondrial diseases.  Semin Neurol . 1996;  16 11-20
• 10 Mariotti C, Savarese N, Suomalainen A. Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA.  J Neurol . 1995;  242 304-312
• 11 Morgan-Hughes J A, Sweeney M G, Cooper J M. Mitochondrial DNA (mtDNA) diseases: correlation of genotype to phenotype.  Biochim Biophys Acta . 1995;  1271 135-140
• 12 Schapira A H, Cock H R. Mitochondrial myopathies and encephalomyopathies.  Eur J Clin Invest . 1999;  29 886-898
• 13 Silvestri G, Bertini E, Servidei S. Maternally inherited cardiomyopathy: a new phenotype associated with the A to G AT nt.3243 of mitochondrial DNA (MELAS mutation).  Muscle Nerve . 1997;  20 221-225
• 14 Sue C M, Karadimas C, Checcarelli N. Differential features of patients with mutations in two COX assembly genes, SURF-1 and SCO2.  Ann Neurol . 2000;  47 589-595
• 15 Wallace D C, Lott M T, Shoffner J M, Ballinger S. Mitochondrial DNA mutations in epilepsy and neurological disease.  Epilepsia . 1994 (suppl 1);  35 (S43-50)
• 16 Damian M S, Seibel P, Reichmann H. Clinical spectrum of the MELAS mutation in a large pedigree.  Acta Neurol Scand . 1995;  92 409-415
• 17 Kerr D S. Protean manifestations of mitochondrial diseases: a minireview.  J Pediatr Hematol Oncol . 1997;  19 279-286
• 18 Anan R, Nakagawa M, Miyata M. Cardiac involvement in mitochondrial diseases: a study on 17 patients with documented mitochondrial DNA defects [see comments].  Circulation . 1995;  91 955-961
• 19 Brockington M, Alsanjari N, Sweeney M G, Morgan-Hughes J A, Scaravilli F, Harding A E. Kearns-Sayre syndrome associated with mitochondrial DNA deletion or duplication: a molecular genetic and pathological study.  J Neurol Sci . 1995;  131 78-87
• 20 Chang T S, Johns D R, Walker D, de la Cruz Z, Maumence I H, Green W R. Ocular clinicopathologic study of the mitochondrial encephalomyopathy overlap syndromes.  Arch Ophthalmol . 1993;  111 1254-1262
• 21 Eagle Jr C R, Hedges T R, Yanoff M. The atypical pigmentary retinopathy of Kearns-Sayre syndrome: a light and electron microscopic study.  Ophthalmology . 1982;  89 1433-1440
• 22 Nakagawa E, Hirano S, Yamanouchi H, Goto Y, Nonaka I, Takashima S. Progressive brainstem and white matter lesions in Kearns-Sayre syndrome: a case report.  Brain Dev . 1994;  16 416-418
• 23 Oldfors A, Fyhr I M, Holme E, Larsson N G, Tulinius M. Neuropathology in Kearns-Sayre syndrome.  Acta Neuropathol (Berl) . 1990;  80 541-546
• 24 Shoffner J M, Lott M T, Voljavec A S, Soueidan S A, Costigan D A, Wallace D C. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.  Proc Natl Acad Sci U S A . 1989;  86 7952-7956
• 25 Swift A C, Singh S D. Hearing impairment and the Kearns-Sayre syndrome.  J Laryngol Otol . 1988;  102 626-762
• 26 Tveskov C, Angelo-Nielsen K. Kearns-Sayre syndrome and dilated cardiomyopathy.  Neurology . 1990;  40 553-554
• 27 Ulicny Jr S K, Detterbeck F C, Hall C D. Sinus dysrhythmia in Kearns-Sayre syndrome.  Pacing Clin Electrophysiol . 1994;  17 991-994
• 28 Wallace D C. Mitochondrial DNA mutations in diseases of energy metabolism.  J Bioenerg Biomembr . 1994;  26 241-250
• 29 Zupanc M L, Moraes C T, Shanske S, Langman C B, Ciafaloni E, DiMauro S. Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes.  Ann Neurol . 1991;  29 680-683
• 30 Zeviani M, Moraes C T, DiMauro S. Deletions of mitochondrial DNA in Kearns-Sayre syndrome: 1988.  Neurology . 1998;  51 1525-1533
• 31 Morris A A. Mitochondrial respiratory chain disorders and the liver.  Liver . 1999;  19 357-368
• 32 Mochizuki H, Joh K, Kawame H. Mitochondrial encephalomyopathies preceded by de-Toni-Debre-Fanconi syndrome or focal segmental glomerulosclerosis.  Clin Nephrol . 1996;  46 347-352
• 33 Bader-Meunier B, Mielot F, Breton-Gorius J. Hematologic involvement in mitochondrial cytopathies in childhood: a retrospective study of bone marrow smears.  Pediatr Res . 1999;  46 158-162
• 34 Inbal A, Avissar N, Shaklai M. Myopathy, lactic acidosis, and sideroblastic anemia: a new syndrome.  Am J Med Genet . 1995;  55 372-378
• 35 Casademont J, Barrientos A, Cardellach F. Multiple deletions of mtDNA in two brothers with sideroblastic anemia and mitochondrial myopathy and in their asymptomatic mother.  Hum Mol Genet . 1994;  3 1945-1949
• 36 Nelson I, Bonne G, Degoul F, Marsac C, Ponsot G, Lestienne P. Kearns-Sayre syndrome with sideroblastic anemia: molecular investigations.  Neuropediatrics . 1992;  23 199-205
• 37 Birch-Machin M A. Mitochondria and skin disease.  Clin Exp Dermatol . 2000;  25 141-146
• 38 Flanigan K M, Lauria G, Griffin J W, Kuncl R W. Age related biology and disease of muscle and nerve.  Neurol Clin . 1998;  16 659-669
• 39 Uusimaa J, Remes A M, Rantala H. Childhood encephalopathies and myopathies: a prospective study in a defined population to assess the frequency of mitochondrial disorders.  Pediatrics . 2000;  105 598-603
• 40 Molnar M, Zanssen S, Buse G, Schroder J M. A large-scale deletion of mitochondrial DNA in a case with pure mitochondrial myopathy and neuropathy.  Acta Neuropathol (Berl) . 1996;  91 654-658
• 41 Stadhouders A M, Jap P H, Winkler H P, Eppenberger H M, Wallimann T. Mitochondrial creatine kinase: a major constituent of pathological inclusions seen in mitochondrial myopathies.  Proc Natl Acad Sci U S A . 1994;  91 5089-5093
• 42 Rago R P, Miles J M, Sufit R L, Spriggs D R, Wilding G. Suramin-induced weakness from hypophosphatemia and mitochondrial myopathy: association of suramin with mitochondrial toxicity in humans.  Cancer . 1994;  73 1954-1959
• 43 Priller J SC, Faber P W, MacDonald M E, Young A B. Frataxin gene of Friedreich's ataxia is targeted to mitochondria.  Annals of Neurology . 1997;  42 265-269
• 44 Colomer J, Iturriaga C, Bestue M. [Aspects of neuropathy in mitochondrial diseases].  Rev Neurol . 2000;  30 1117-1121
• 45 Chu C C, Huang C C, Fang W, Chu N S, Pang C Y, Wei Y H. Peripheral neuropathy in mitochondrial encephalomyopathies.  Eur Neurol . 1997;  37 110-115
• 46 Fadic R, Russell J A, Vedanarayanan V V, Lehar M, Kuncl R W, Johns D R. Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease.  Neurology . 1997;  49 239-245
• 47 Hirano M, Silvestri G, Blake D M. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder.  Neurology . 1994;  44 721-727
• 48 Huang C C, Chu C C, Pang C Y, Wei Y H. Tissue mosaicism in the skeletal muscle and sural nerve biopsies in the MELAS syndrome.  Acta Neurol Scand . 1999;  99 125-129
• 49 Klimek A, Suomalainen A, Bratosiewicz J, Niewinowska-Rupf K, Bogucki A, Liberski P P. A case of mitochondrial myopathy with MELAS-like features and polyneuropathy: ultrastructural and molecular studies.  Pol J Pathol . 1997;  48 197-200
• 50 Melberg A, Lundberg P O, Henriksson K G, Olsson Y, Stalberg E. Muscle-nerve involvement in autosomal dominant progressive external ophthalmoplegia with hypogonadism.  Muscle Nerve . 1996;  19 751-757
• 51 Mizusawa H, Ohkoshi N, Watanabe M, Kanazawa I. Peripheral neuropathy of mitochondrial myopathies.  Rev Neurol (Paris) . 1991;  147 501-507
• 52 Rusanen H, Majamaa K, Tolonen U, Remes A M, Myllyla R, Hassinen I E. Demyelinating polyneuropathy in a patient with the tRNA(Leu)(UUR) mutation at base pair 3243 of the mitochondrial DNA [see comments].  Neurology . 1995;  45 1188-1192
• 53 Schroder J M. Neuropathy associated with mitochondrial disorders.  Brain Pathol . 1993;  3 177-190
• 54 van Domburg H P, Gabreels-Festen A A, Gabreels F J. Mitochondrial cytopathy presenting as hereditary sensory neuropathy with progressive external ophthalmoplegia, ataxia and fatal myoclonic epileptic status.  Brain . 1996;  119 997-1010
• 55 Molnar M, Neudecker S, Schroder J M. Increase of mitochondria in vasa nervorum of cases with mitochondrial myopathy, Kearns-Sayre syndrome, progressive external ophthalmoplegia and MELAS.  Neuropathol Appl Neurobiol . 1995;  21 432-439